Web_Admin, Author at Cycle Pharma

About Web_Admin

This author has not yet filled in any details.
So far Web_Admin has created 7 blog entries.

Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile

News, Nityr

Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile

By Web_Admin| November 22nd, 2018|News, Nityr|

Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.

Generics, News

Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.

By Web_Admin| August 29th, 2018|Generics, News|

Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs

News, Nityr

Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs

By Web_Admin| December 12th, 2017|News, Nityr|

Cycle Pharmaceuticals launches free trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ dietary needs

News, Nityr

Cycle Pharmaceuticals launches free trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ dietary needs

By Web_Admin| November 10th, 2017|News, Nityr|

Cycle Pharmaceuticals Receives FDA Approval and Launches Ketorolac Tromethamine Injection 30mg/mL in the U.S.

Generics, News

Cycle Pharmaceuticals Receives FDA Approval and Launches Ketorolac Tromethamine Injection 30mg/mL in the U.S.

By Web_Admin| September 19th, 2017|Generics, News|

Cycle Pharmaceuticals Partners with Cardinal as the Logistic Provider for Nityr in U.S.

News, Nityr

Cycle Pharmaceuticals Partners with Cardinal as the Logistic Provider for Nityr in U.S.

By Web_Admin| August 7th, 2017|News, Nityr|

First recommendation for HT-1 treatment in Quebec by INESSS

News

First recommendation for HT-1 treatment in Quebec by INESSS

By Web_Admin| June 2nd, 2017|News|